An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) will release its second quarter 2022 financial results on August 8, 2022, before market open. A conference call will be hosted by President Nikhil Lalwani and CFO Stephen P. Carey at 8:00 a.m. ET. Investors can join the call by dialing 800-225-9448 or via webcast at www.anipharmaceuticals.com. A replay will be available shortly after the call for two weeks. ANI focuses on developing and marketing prescription pharmaceutical products addressing high unmet medical needs.
Positive
Scheduled release of Q2 2022 financial results may indicate timely financial transparency.
Focus on developing high-quality branded and generic prescription products may bolster market position.
Negative
None.
BAUDETTE, Minn.--(BUSINESS WIRE)--
ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its second quarter 2022 financial results on Monday, August 8, 2022, prior to market open.
Nikhil Lalwani, President and Chief Executive Officer, and Stephen P. Carey, Senior Vice President, Finance, and Chief Financial Officer, will host a conference call to discuss the results as follows:
A replay of the conference call will be available within two hours of the call’s completion and will remain accessible for two weeks by dialing 800-753-6121 and entering access code 7163806.
About ANI
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) is a diversified biopharmaceutical company serving patients by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by building a successful Purified Cortrophin® Gel franchise, strengthening our generics business with enhanced development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com.
Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc. 212-452-2793
lwilson@insitecony.com
Media:
Faith Pomeroy-Ward, Director, Commercial Market Development, ANI Pharmaceuticals 817-807-8044
Faith.pomeroyward@anipharmaceuticals.com
SOURCE: ANI Pharmaceuticals, Inc.
Source: ANI Pharmaceuticals, Inc.
FAQ
When will ANI Pharmaceuticals release its Q2 2022 financial results?
ANI Pharmaceuticals will release its Q2 2022 financial results on August 8, 2022, prior to market open.
What time is the ANI Pharmaceuticals Q2 2022 conference call?
The Q2 2022 conference call for ANI Pharmaceuticals is scheduled for 8:00 a.m. ET on August 8, 2022.
How can I access the ANI Pharmaceuticals conference call?
You can access the ANI Pharmaceuticals conference call by dialing 800-225-9448 or via webcast at www.anipharmaceuticals.com.
Is there a replay of the ANI Pharmaceuticals Q2 2022 conference call?
Yes, a replay of the ANI Pharmaceuticals conference call will be available within two hours of completion and accessible for two weeks.
What is the main focus of ANI Pharmaceuticals?
ANI Pharmaceuticals focuses on developing, manufacturing, and marketing high-quality branded and generic prescription pharmaceutical products.
